Imaging3 unveils Dominion
Imaging3 Inc. unveiled its patented technology, known as the Dominion, at RSNA 2006. The Dominion uses high-resolution photo-fluoroscopy to produce 3D diagnostic images in real-time. Because these 3D images are instantly constructed in real-time, they can be used for any current or new medical procedures in which multiple frames of reference are required to perform medical procedures on or in the human body.
The Dominion also can emulate other imaging technology, such as CT scans, and does so at a fraction of the cost. The Dominion is mobile, will fit through a standard room door, and is powered by a standard wall outlet.
Dean Janes, chairman and CEO of Imaging3, appeared at a press conference during RSNA to discuss the Dominion product and its transformational role in the medical imaging device market. "Real-time 3D, as a medium for display and imaging is here now, and its effect on technology over the next few decades, especially the medical device market, is ushering in a broad advancement in the role of radiology. No longer just a diagnostic tool, real-time three dimensional imaging is shifting these devices into a proactive role in the operating room,'' he said.
The company is planning for beta testing of the prototype to begin the clinical trials in January 2007, with the luminary sites expected to come on line in late 2007, following FDA approval.
The Dominion also can emulate other imaging technology, such as CT scans, and does so at a fraction of the cost. The Dominion is mobile, will fit through a standard room door, and is powered by a standard wall outlet.
Dean Janes, chairman and CEO of Imaging3, appeared at a press conference during RSNA to discuss the Dominion product and its transformational role in the medical imaging device market. "Real-time 3D, as a medium for display and imaging is here now, and its effect on technology over the next few decades, especially the medical device market, is ushering in a broad advancement in the role of radiology. No longer just a diagnostic tool, real-time three dimensional imaging is shifting these devices into a proactive role in the operating room,'' he said.
The company is planning for beta testing of the prototype to begin the clinical trials in January 2007, with the luminary sites expected to come on line in late 2007, following FDA approval.